Trials / Unknown
UnknownNCT05476536
Effectiveness of Technology for Metabolic Diseases Combined Sarcopenia
The Effectiveness of Technology Combined Self-health Management and Home Care Model Improved the Metabolic Diseases, Sarcopenia, and Serum Inflammation and Metabolic Markers Among Middle-aged and Elderly Individuals in the Community
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Chang Gung University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 40 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
The lifestyle program intervention program focusing on healthy dietary habit and exercise effectively prevents metabolic syndrome, sarcopenia or frailty. Thus, the purpose of this study was to assess the efficacy of intervention program on metabolic syndrome subjects in Taiwan.
Detailed description
The study is a 2-parallel groups' randomized controlled trial. Participants with metabolic syndrome (three or more risk factors - triglycerides (TG) \>150 mg/dL, systolic blood pressure (SBP) ≥130 mm Hg, diastolic blood pressure (DBP) ≥85 mm Hg, or fasting blood glucose≥100 mg/dL; high-density lipoprotein cholesterol\<50 mg/dL, or waist circumference ≥80 cm) are enrolled. The four community units are randomized to receive a lifestyle intervention (intervention arm) or an education leaflet (control arm). The parameters are obtained from physical examination and biochemical assessments by well-trained case manager at baseline and 4th months. All participants complete a structured questionnaire, including basic information, SOF, physical performance, physical activity, and food-frequency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | self-management skills and healthy technology APP | self-management skills and healthy technology APP |
Timeline
- Start date
- 2023-02-15
- Primary completion
- 2023-07-31
- Completion
- 2023-07-31
- First posted
- 2022-07-27
- Last updated
- 2023-02-08
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05476536. Inclusion in this directory is not an endorsement.